Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Jun;28(3):881–886. doi: 10.1128/iai.28.3.881-886.1980

Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.

E Yarkoni, H J Rapp
PMCID: PMC551033  PMID: 6995325

Abstract

The influence of mineral ol, squalane, squalene, hexadecane, or peanut oil and of the concentration of Tween 80 on the immunotherapeutic capability of emulsified Mycobacterium bovis Bacillus Calmette-Guérin (BCG) cell walls was studied in guinea pigs, each with an established dermal transplant of a syngeneic hepatocarcinoma and tumor cells in the draining lymph node. Immunotherapy consisted of an intratumoral injection of emulsified cell walls. Conditions were established under which therapeutically effective emulsions could be made with mineral oil, squalane, squalene, or hexadecane. Emulsions made with peanut oil failed to cause tumor regression. Emulsions of squalene or hexadecane were effective substitutes for mineral oil as carriers of cell walls in the absence of added Tween or at a Tween concentration one-hundredth of that used to stabilize the mineral oil-containing emulsions. Cell wall emulsions made with squalane were therapeutically effective over the same range of Tween concentrations used to prepare emulsions containing mineral oil. Cell wall emulsions made without added Tween demonstrated effective antitumor activity even after autoclaving. Emulsions made with Tween separated after autoclaving. Emulsions of whole killed BCG were immunotherapeutically as active as those made with cell walls.

Full text

PDF
881

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bekierkunst A. Immunotherapy of cancer with nonliving mycobacteria and cord factor (trehalose-6,6'-dimycolate) in aqueous medium. J Natl Cancer Inst. 1976 Oct;57(4):963–964. doi: 10.1093/jnci/57.4.963. [DOI] [PubMed] [Google Scholar]
  2. Bekierkunst A., Wang L., Toubiana R., Lederer E. Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression. Infect Immun. 1974 Nov;10(5):1044–1050. doi: 10.1128/iai.10.5.1044-1050.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bingham E., Stemmer K. L., Falk H. L. The effects of repeated injections of certain adjuvants on chemical carcinogenesis. Ann Allergy. 1967 Dec;25(12):684–690. [PubMed] [Google Scholar]
  4. Cohen H. A., Bekierkunst A. Treatment of mycosis fungoides with heat-killed BCG and cord factor. Dermatologica. 1979;158(2):104–116. doi: 10.1159/000250751. [DOI] [PubMed] [Google Scholar]
  5. Hilleman M. R., Woodhour A. F., Friedman A., Phelps A. H. Studies for safety of adjuvant 65. Ann Allergy. 1972 Aug;30(8):477–483. [PubMed] [Google Scholar]
  6. Kleinschuster S. J., Rapp H. J., Lueker D. C., Kainer R. A. Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine. J Natl Cancer Inst. 1977 Jun;58(6):1807–1814. doi: 10.1093/jnci/58.6.1807. [DOI] [PubMed] [Google Scholar]
  7. MCCARTHY R. D. MAMMALIAN METABOLISM OF STRAIGHT-CHAIN SATURATED HYDROCARBONS. Biochim Biophys Acta. 1964 Feb 24;84:74–79. doi: 10.1016/0926-6542(64)90102-7. [DOI] [PubMed] [Google Scholar]
  8. POTTER M. Plasma cell neoplasia in a single host: a mosaic of different protein-producing cell types. J Exp Med. 1962 Feb 1;115:339–356. doi: 10.1084/jem.115.2.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rapp H. J. A guinea pig model for tumor immunology. A summary. Isr J Med Sci. 1973 Mar;9(3):366–374. [PubMed] [Google Scholar]
  10. Yarkoni E., Meltzer M. S., Rapp H. J. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration. Int J Cancer. 1977 Jun 15;19(6):818–821. doi: 10.1002/ijc.2910190612. [DOI] [PubMed] [Google Scholar]
  11. Yarkoni E., Rapp H. J. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls. Infect Immun. 1979 Sep;25(3):1087–1089. doi: 10.1128/iai.25.3.1087-1089.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yarkoni E., Rapp H. J. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria. Cancer Res. 1979 Feb;39(2 Pt 1):535–537. [PubMed] [Google Scholar]
  13. Yarkoni E., Rapp H. J. Influence of surfactant concentration on the antitumor activity of emulsified components of mycobacteria. Cancer Res. 1980 Apr;40(4):975–978. [PubMed] [Google Scholar]
  14. Yarkoni E., Rapp H. J. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil. Cancer Res. 1979 May;39(5):1518–1520. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES